Delving into the Latest Updates on Beijing Tri Prime Gene Pharmaceutical Co., Ltd. with Synapse

Overview

Interferon is the first line of innate defense against viruses infection.Interferon α1b is a major antiviral subtype of interferon family.SARS-CoV-2 have evolved several mechanisms to block interferon induction.Interferon α1b, has been approved for the antiviral clin. use for many years, showing strong in vitro antiviral activity against SARS-CoV-2.Preliminary clin. studies including type I interferon have showed critical pos. efficiency on COVID-19 treatment and prevention.A clin. trial with a larger cohort of infected patients that are randomized to treatment with interferon-alpha or to a placebo is ongoing.

Open Access (OA) Online-First Publishing of Research Papers on COVID-19

Progress of interferon a1b research and clinical use against SARS-CoV-2

Author: Liu, Jin-Yi ; Lin, Fu-Yu ; Cheng, Yong-Qing

Interferon is the first line of innate defense against viruses infection.Interferon a1b is a major antiviral subtype of interferon family.SARS-CoV-2 have evolved several mechanisms to block interferon induction.Interferon α1b, has been approved for the antiviral clin. use for many years, showing strong in-vitro antiviral activity against SARS-CoV-2.Preliminary clin. studies including type I interferon have showed critical pos. efficiency on COVID-19 treatment and prevention.A clin. trial with a larger cohort of infected patients that are randomized to treatment with interferon-alpha or to a placebo is ongoing.

100 Deals associated with Beijing Tri Prime Gene Pharmaceutical Co., Ltd.

Login to view more data

100 Translational Medicine associated with Beijing Tri Prime Gene Pharmaceutical Co., Ltd.

Login to view more data